LSV Asset Management’s PharMerica Corporation PMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-375,040
| Closed | -$11M | – | 1025 |
|
|
2017
Q3 | $11M | Sell |
375,040
-102,910
| -22% | -$2.88M | 0.02% | 468 |
|
|
2017
Q2 | $12.5M | Hold |
477,950
| – | – | 0.02% | 434 |
|
|
2017
Q1 | $11.2M | Buy |
477,950
+56,400
| +13% | +$1.39M | 0.02% | 446 |
|
|
2016
Q4 | $10.6M | Buy |
421,550
+101,471
| +32% | +$2.56M | 0.02% | 458 |
|
|
2016
Q3 | $8.98M | Buy |
320,079
+37,196
| +13% | +$953K | 0.02% | 451 |
|
|
2016
Q2 | $6.97M | Buy |
282,883
+142,283
| +101% | +$3.53M | 0.01% | 473 |
|
|
2016
Q1 | $3.11M | Buy |
140,600
+87,300
| +164% | +$2.32M | 0.01% | 592 |
|
|
2015
Q4 | $1.86M | Sell |
53,300
-408,409
| -88% | -$12.8M | ﹤0.01% | 665 |
|
|
2015
Q3 | $13.1M | Sell |
461,709
-205,693
| -31% | -$6.91M | 0.03% | 329 |
|
|
2015
Q2 | $22.2M | Sell |
667,402
-202,294
| -23% | -$6.21M | 0.05% | 268 |
|
|
2015
Q1 | $24.5M | Sell |
869,696
-132,400
| -13% | -$3.29M | 0.05% | 250 |
|
|
2014
Q4 | $20.8M | Buy |
1,002,096
+38,700
| +4% | +$919K | 0.04% | 267 |
|
|
2014
Q3 | $23.5M | Sell |
963,396
-138,898
| -13% | -$3.68M | 0.05% | 246 |
|
|
2014
Q2 | $31.5M | Sell |
1,102,294
-337,700
| -23% | -$9.39M | 0.07% | 210 |
|
|
2014
Q1 | $40.3M | Sell |
1,439,994
-184,700
| -11% | -$4.53M | 0.09% | 176 |
|
|
2013
Q4 | $34.9M | Sell |
1,624,694
-81,406
| -5% | -$1.48M | 0.08% | 195 |
|
|
2013
Q3 | $22.6M | Sell |
1,706,100
-7,800
| -0.5% | -$105K | 0.06% | 240 |
|
|
2013
Q2 | $23.8M | Buy |
+1,713,900
| New | +$24.3M | 0.06% | 222 |
|
LSV Asset Management's PMC Position: Q4 2017 in Review
LSV Asset Management sold out of PharMerica Corporation (PMC) in Q4 2017, closing a stake of 375,040 shares — an estimated $11M sold.
LSV Asset Management first reported a position in PMC in Q2 2013 and held it in 18 quarters. The position peaked at $40.3M in Q1 2014. 0 funds tracked by Wall St. Rank hold PMC as of Q4 2017.
- LSV Asset Management reported no remaining PharMerica Corporation position as of Q4 2017 after selling out during the quarter.
- LSV Asset Management sold 375,040 PharMerica Corporation shares in Q4 2017, an estimated $11M.
- LSV Asset Management first reported a position in PharMerica Corporation in Q2 2013 and held it in 18 quarters.
- LSV Asset Management's PharMerica Corporation position peaked at $40.3M in Q1 2014.
- 0 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2017.
Based on LSV Asset Management's 13F filing for Q4 2017, filed 1 Feb 2018.